tiprankstipranks
Trending News
More News >
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market

TransMedics Group (TMDX) Income Statement

Compare
1,716 Followers

TransMedics Group Income Statement

Last quarter (Q3 2025), TransMedics Group's total revenue was $143.82M, an increase of 32.24% from the same quarter last year. In Q3, TransMedics Group's net income was $24.32M. See TransMedics Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 441.54M$ 241.62M$ 93.46M$ 30.26M$ 25.64M
Gross Profit
$ 262.08M$ 154.09M$ 65.27M$ 21.16M$ 16.64M
Operating Expenses
$ 224.59M$ 182.82M$ 96.71M$ 60.59M$ 43.02M
Depreciation and Amortization
$ 19.76M$ 8.18M$ 3.48M$ 1.82M$ 1.58M
EBITDA
$ 69.95M$ -7.70M$ -28.96M$ -38.49M$ -23.15M
Operating Income
$ 37.50M$ -28.73M$ -31.44M$ -39.43M$ -26.38M
Other Income/Expenses
$ -1.72M$ 2.06M$ -4.73M$ -4.75M$ -2.33M
Pretax Income
$ 35.78M$ -26.67M$ -36.16M$ -44.18M$ -28.72M
Net Income
$ 35.46M$ -25.03M$ -36.23M$ -44.22M$ -28.75M
Per Share Metrics
Basic EPS
$ 1.07$ -0.77$ -1.23$ -1.60$ -1.16
Diluted EPS
$ 1.01$ -0.77$ -1.23$ -1.60$ -1.16
Weighted Average Shares Outstanding
33.23M 32.52M 29.56M 27.62M 24.70M
Weighted Average Shares Outstanding (Diluted)
35.22M 32.52M 29.56M 27.62M 24.70M
Currency in USD

TransMedics Group Earnings and Revenue History